Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS) by Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Si-Qi Zhang, Ke-Rui Wang, Ke-Rui Wang, Shi-Nan Wu, Shi-Nan Wu, Meng-Yuan Wang, Meng-Yuan Wang, Cui-Ting Chen, Cui-Ting Chen, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong

Get full text